Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.1086
-0.0010 (-0.91%)
At close: Jun 12, 2026
Episurf Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 26 | 20.2 | 20.6 | 19.8 | 6.6 | 6.5 |
Other Revenue | 0.5 | - | - | - | - | - |
| 26.5 | 20.2 | 20.6 | 19.8 | 6.6 | 6.5 | |
Revenue Growth (YoY) | 38.74% | -1.94% | 4.04% | 200.00% | 1.54% | 30.00% |
Cost of Revenue | 12.9 | 10.1 | 9.9 | 61.6 | 36.2 | 35 |
Gross Profit | 13.6 | 10.1 | 10.7 | -41.8 | -29.6 | -28.5 |
Selling, General & Admin | 59.5 | 30.9 | 36.5 | 46.6 | 40.3 | 34 |
Other Operating Expenses | 29.1 | 28.9 | 42.4 | -0.3 | -0.3 | -0.4 |
Operating Expenses | 97.9 | 67.9 | 87.9 | 55 | 47.4 | 41 |
Operating Income | -84.3 | -57.8 | -77.2 | -96.8 | -77 | -69.5 |
Interest Expense | -5.5 | -0.6 | -1 | -0.9 | -0.7 | -0.2 |
Interest & Investment Income | 0.5 | 0.5 | 2.2 | 3.1 | 0.5 | 0.4 |
Other Non Operating Income (Expenses) | 3.1 | - | 0.1 | 0.1 | - | -0.1 |
EBT Excluding Unusual Items | -86.2 | -57.9 | -75.9 | -94.5 | -77.2 | -69.4 |
Other Unusual Items | - | - | - | - | - | 0.1 |
Pretax Income | -86.2 | -57.9 | -75.9 | -94.5 | -77.2 | -69.3 |
Income Tax Expense | 0.4 | 0.3 | 0.1 | 0.3 | 0.1 | - |
Net Income | -86.6 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Net Income to Common | -86.6 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Shares Outstanding (Basic) | 1,302 | 987 | 479 | 314 | 267 | 227 |
Shares Outstanding (Diluted) | 1,302 | 987 | 479 | 314 | 267 | 227 |
Shares Change (YoY) | 126.25% | 105.90% | 52.50% | 17.84% | 17.67% | 39.80% |
EPS (Basic) | -0.07 | -0.06 | -0.16 | -0.30 | -0.29 | -0.31 |
EPS (Diluted) | -0.07 | -0.06 | -0.16 | -0.30 | -0.29 | -0.31 |
Free Cash Flow | -45.6 | -55.3 | -71.4 | -84.8 | -69.5 | -59.8 |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.15 | -0.27 | -0.26 | -0.26 |
Gross Margin | 51.32% | 50.00% | 51.94% | -211.11% | - | - |
Operating Margin | -318.11% | -286.14% | -374.76% | -488.89% | -1166.67% | -1069.23% |
Profit Margin | -326.79% | -288.12% | -368.93% | -478.79% | -1171.21% | -1066.15% |
Free Cash Flow Margin | -172.07% | -273.76% | -346.60% | -428.28% | -1053.03% | -920.00% |
EBITDA | -81.9 | -55.3 | -74.1 | -94.1 | -74.4 | -66.6 |
EBITDA Margin | - | -273.76% | - | - | - | - |
D&A For EBITDA | 2.4 | 2.5 | 3.1 | 2.7 | 2.6 | 2.9 |
EBIT | -84.3 | -57.8 | -77.2 | -96.8 | -77 | -69.5 |
EBIT Margin | - | -286.14% | - | - | - | - |
Revenue as Reported | 29.1 | 22.8 | 20.7 | 20.1 | 18.2 | 13.8 |